Sunday, March 16, 2025 10:42:23 AM
This is one big disaster. IMTX has to raise capital at a terrible valuation. Management has messed this entire company up to a point that now they can only do some form of bad deal to bring capital in. Another short that has been good so far but I expect it to be even better as time goes on.
They have a decent portfolio of products but managements stupid approach has not gotten them much money.
for how many years did management not want to raise money because they thought they were worth money than the market cap had them at.
NOW THEY ARE EVEN LOWER MARKET CAP AND RAISING CAPITAL IS NEARLY IMPOSSIBLE.
Stupid management equals lower stock price which then equals shareholder losses.
Another short sell that will yield big results.
They have a decent portfolio of products but managements stupid approach has not gotten them much money.
for how many years did management not want to raise money because they thought they were worth money than the market cap had them at.
NOW THEY ARE EVEN LOWER MARKET CAP AND RAISING CAPITAL IS NEARLY IMPOSSIBLE.
Stupid management equals lower stock price which then equals shareholder losses.
Another short sell that will yield big results.
Recent IMTX News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 09:03:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/12/2026 11:08:04 AM
- Immatics Announces First Quarter 2026 Financial Results and Business Update • GlobeNewswire Inc. • 05/12/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/21/2026 02:40:20 PM
- Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting • GlobeNewswire Inc. • 04/21/2026 02:25:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/17/2026 07:06:45 PM
- PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma • GlobeNewswire Inc. • 04/17/2026 07:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:41:57 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:39:50 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:39:40 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:36:57 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:31:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:27:51 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:26:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:15:35 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:08:32 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:07:18 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 10:49:10 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:01:29 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/05/2026 12:12:59 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2026 12:00:37 PM
- Immatics Announces Full Year 2025 Financial Results and Business Update • GlobeNewswire Inc. • 03/05/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/12/2026 09:09:23 PM
